Key statistics
As of last trade MacroGenics Inc (MGNX:NSQ) traded at 3.23, 9.28% above its 52-week low of 2.95, set on Sep 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.21 |
---|---|
High | 3.31 |
Low | 3.15 |
Bid | 3.22 |
Offer | 3.23 |
Previous close | 3.21 |
Average volume | 571.68k |
---|---|
Shares outstanding | 62.76m |
Free float | 61.11m |
P/E (TTM) | -- |
Market cap | 201.47m USD |
EPS (TTM) | -1.57 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 20:21 GMT.
More ▼
- MacroGenics to Participate in Upcoming Investor Conferences
- MacroGenics Announces Leadership Transition
- MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call
- MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024
- MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
- MacroGenics Provides Vobramitamab Duocarmazine Update
- MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with Incyte
- MacroGenics to Participate in Upcoming Investor Conference
- MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call
- MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
More ▼